The US Food and Drug Administration has approved foot sagging indicators generated by wearable sensors as longitudinal outcome indicators for rare neurological disease research in accordance with the “Accelerated Rare Disease Therapy Development Program”.

The US Food and Drug Administration has approved foot sagging indicators generated by wearable sensors as longitudinal outcome indicators for rare neurological disease research in accordance with the “Accelerated Rare Disease Therapy Development Program”.